Inhibiting the HIF2 protein was found to promote repair processes in a mouse model of lung injury, and may be a strategy for ...

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

Study uncovers the impact of myocardial infarction on the cardiac conduction system, revealing insights into arrhythmogenesis ...

Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile ...

How does exercise benefit health? Molecules called exerkines partly regulate its effects and provide therapeutic targets to ...

Ace investor Shankar Sharma, a.k.a. Le Grand Fromage, unveils the 'SSIPHO' method - blending breakthrough medical science with cutting-edge investment strategy.

The aberrant immune response against self-antigens occurring in autoimmune diseases involves dysregulation of members of intracellular signal transduction pathways such as interleukin-2-inducible T ...

Tenalisib is under clinical development by Rhizen Pharmaceuticals and currently in Phase II for Follicular Lymphoma.

Tenalisib is under clinical development by Rhizen Pharmaceuticals and currently in Phase II for Marginal Zone B-cell Lymphoma.

Clinical Electrophysiology journal showed that when acute procedural success is attained in a subset of patients with ...